Prevalence of Bronchiolitis Obliterans Syndrome (BOS) 2 years post-transplant [clinicaltrials_resource:1f5b629f71ba55fcd43d3b0265335f73]
BOS was defined as a sustained decrease in forced Expiratory Volume in one second (FEV1) of at least 20% from the patient's maximum post-operative values in the absence of other causes.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Prevalence of Bronchiolitis Obliterans Syndrome (BOS) 2 years post-transplant [clinicaltrials_resource:1f5b629f71ba55fcd43d3b0265335f73]
BOS was defined as a sustained decrease in forced Expiratory Volume in one second (FEV1) of at least 20% from the patient's maximum post-operative values in the absence of other causes.
Bio2RDF identifier
1f5b629f71ba55fcd43d3b0265335f73
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1f5b629f71ba55fcd43d3b0265335f73
measure [clinicaltrials_vocabulary:measure]
Prevalence of Bronchiolitis Obliterans Syndrome (BOS)
time frame [clinicaltrials_vocabulary:time-frame]
2 years post-transplant
description
BOS was defined as a sustained ...... n the absence of other causes.
identifier
clinicaltrials_resource:1f5b629f71ba55fcd43d3b0265335f73
title
Prevalence of Bronchiolitis Obliterans Syndrome (BOS) 2 years post-transplant
@en
type
label
Prevalence of Bronchiolitis Ob ...... b629f71ba55fcd43d3b0265335f73]
@en